34 patients with RA carrying HLA-DRB1 ‘shared epitope’ allele. 18 received autologous monocyte-derived tolDC intradermally at a dose of between 0.6 to 4.5×106 cells (depending on yield) while 16 were controls. The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.